Abstract
Losartan is a specific angiotensin II receptor antagonist. Although the teratogenic effects of angiotensin converting enzyme (ACE) inhibitors are well documented there are limited reports of losartan induced fetal toxicity. The authors report a case of incomplete ossification of skull bones, transient oliguria and feed intolerance in a newborn followinginutero exposure to losartan.
References
Saji H, Yamanaker M, Hagiwara A, Jjeri R. Losartan and fetal toxic effects.Lancet 2001; 357:363.
Sorensen AM, Christensen S, Jonassen TE, Andersen D, Petersen JS. Teratogenic effects of ACE-inhibitors and Angiotensin II receptor antagonists (Article in Danish).Ugeker Laegar Mar 2; 160(1) : 1460–1464.
Stevenson KM, Gibson KJ, Lumbers ER. Effects of Losartan on the cardiovascular system, renal haemodynamics and function and lung liquid flow in fetal sheep.Clin Exp Pharmacol Physiol 1996; 23:125–133.
Lambot MA, Vermeyten D, Noel JC. Angiotensin-II receptor inhibitors in pregnancy.Lancet 2001; 357:1619–1620.
Hinsberger A, Wingen AM, Hoyer PF. Angiotensin II receptor inhibitors in pregnancy.Lancet 2001; 357:1620.
Chung NA, Lip GHH, Beevers M, Beevers DG. Angiotensin II receptor inhibitors in pregnancy.Lancet 2001; 357:1620.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nayar, B., Singhal, A., Aggarwal, R. et al. Losartan induced fetal toxicity. Indian J Pediatr 70, 923–924 (2003). https://doi.org/10.1007/BF02730601
Issue Date:
DOI: https://doi.org/10.1007/BF02730601